Rho/PAK signaling: a key driver of anthracycline and taxane resistance in breast cancer
Fields of Study & Subjects
Protein Kinase Regulation and GTPase Signaling
Cancer Treatment and Pharmacology
Melanoma and MAPK Pathways
Publication details
- Journal / source
- Medical Oncology
- Publisher
- Springer Science and Business Media LLC
- Volume
- 43
- Issue
- 6
- Publication date
- 25 April 2026
- Language
- EN